Having trouble accessing articles? Reset your cache.

Aspen, Sigma Pharmaceuticals Ltd. deal

Aspen will acquire Sigma's pharmaceuticals division for A$900 million ($800.5 million)

Read the full 114 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE